Symbols / LFWD
LFWD Chart
About
Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals' post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as ReWalk Robotics Ltd. and changed its name to Lifeward Ltd. in September 2024. Lifeward Ltd. was incorporated in 2001 and is based in Yokneam Illit, Israel.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 7.64M |
| Enterprise Value | 5.68M | Income | -29.84M | Sales | 24.50M |
| Book/sh | 9.08 | Cash/sh | 1.32 | Dividend Yield | — |
| Payout | 0.00% | Employees | 80 | IPO | — |
| P/E | — | Forward P/E | -1.90 | PEG | — |
| P/S | 0.31 | P/B | 0.55 | P/C | — |
| EV/EBITDA | -0.34 | EV/Sales | 0.23 | Quick Ratio | 0.89 |
| Current Ratio | 1.92 | Debt/Eq | 1.86 | LT Debt/Eq | — |
| EPS (ttm) | -34.92 | EPS next Y | -2.64 | EPS Growth | — |
| Revenue Growth | 1.10% | Earnings | 2026-03-05 | ROA | -32.29% |
| ROE | -127.95% | ROIC | — | Gross Margin | 36.06% |
| Oper. Margin | -50.69% | Profit Margin | -121.82% | Shs Outstand | 1.52M |
| Shs Float | 1.46M | Short Float | 10.95% | Short Ratio | 4.90 |
| Short Interest | — | 52W High | 5.23 | 52W Low | 0.40 |
| Beta | 0.14 | Avg Volume | 508.66K | Volume | 64.90K |
| Target Price | $87.00 | Recom | None | Prev Close | $4.59 |
| Price | $5.01 | Change | 9.04% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$87.00
Mean price target
2. Current target
$5.52
Latest analyst target
3. DCF / Fair value
$-110.31
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$5.52
Low
$54.00
High
$120.00
Mean
$87.00
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-11-18 | main | HC Wainwright & Co. | Buy → Buy | $5 |
| 2025-03-11 | main | Lake Street | Buy → Buy | $4 |
| 2025-03-11 | reit | HC Wainwright & Co. | Buy → Buy | $13 |
| 2025-02-20 | main | Lake Street | Buy → Buy | $5 |
| 2025-02-20 | reit | HC Wainwright & Co. | Buy → Buy | $13 |
| 2025-02-10 | init | Laidlaw & Co. | — → Buy | $10 |
| 2024-11-13 | reit | HC Wainwright & Co. | Buy → Buy | $13 |
| 2024-08-16 | main | HC Wainwright & Co. | Buy → Buy | $13 |
| 2024-05-16 | main | HC Wainwright & Co. | Buy → Buy | $13 |
| 2024-04-15 | reit | HC Wainwright & Co. | Buy → Buy | $9 |
| 2024-02-28 | reit | HC Wainwright & Co. | Buy → Buy | $3 |
| 2023-11-15 | reit | HC Wainwright & Co. | Buy → Buy | $3 |
| 2023-08-14 | reit | HC Wainwright & Co. | Buy → Buy | $3 |
| 2023-08-10 | reit | HC Wainwright & Co. | Buy → Buy | $3 |
| 2023-07-03 | reit | HC Wainwright & Co. | Buy → Buy | $3 |
| 2023-05-12 | reit | HC Wainwright & Co. | Buy → Buy | $3 |
| 2023-02-24 | reit | HC Wainwright & Co. | — → Buy | $3 |
| 2022-11-15 | main | HC Wainwright & Co. | — → Buy | $3 |
| 2022-08-10 | main | HC Wainwright & Co. | — → Buy | $3 |
| 2021-03-01 | main | HC Wainwright & Co. | — → Buy | $4 |
- LFWD Stock Sinks To Record Low On Second Reverse Split In Two Years - Stocktwits Fri, 20 Feb 2026 16
- Medtech firm Lifeward consolidates shares 12-to-1 to stay on Nasdaq - Stock Titan Fri, 20 Feb 2026 13
- Lifeward Ltd. Announces 1-for-12 Reverse Stock Split Effective February 24, 2026 - Quiver Quantitative Fri, 20 Feb 2026 13
- Lifeward (LFWD) Implements 1-for-12 Reverse Stock Split - GuruFocus Fri, 20 Feb 2026 15
- Lifeward Granted Nasdaq Extension to Regain Listing Compliance - The Globe and Mail ue, 10 Feb 2026 08
- Lifeward stock drops as reverse split announced By Investing.com - Investing.com Nigeria Fri, 20 Feb 2026 15
- Oramed and Lifeward Announce Strategic Transaction - PR Newswire ue, 13 Jan 2026 08
- Lifeward Enters High-Interest Secured Promissory Note Financing - TipRanks hu, 19 Feb 2026 22
- Even With A 27% Surge, Cautious Investors Are Not Rewarding Lifeward Ltd.'s (NASDAQ:LFWD) Performance Completely - simplywall.st hu, 25 Sep 2025 07
- Market Sentiment Around Loss-Making Lifeward Ltd. (NASDAQ:LFWD) - Yahoo Finance Fri, 14 Nov 2025 08
- LFWD stock sinks to record low on second reverse split in two years - MSN Sat, 21 Feb 2026 05
- Spinal cord injury patients get new access as Aetna covers ReWalk exoskeleton - Stock Titan ue, 17 Feb 2026 13
- Lifeward Seeks Shareholder Backing for Oratech Deal and Lifeline Financing - The Globe and Mail ue, 10 Feb 2026 08
- $LFWD stock is up 15% today. Here's what we see in our data. - Quiver Quantitative Wed, 03 Dec 2025 08
- Lifeward (Nasdaq: LFWD) adds Humana approval, taking ReWalk 7 access to 47% of Medicare Advantage - Stock Titan Wed, 03 Dec 2025 08
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 50000 | — | — | Stock Award(Grant) at price 0.00 per share. | LYNCH JEANNINE | Officer | — | 2025-12-11 00:00:00 | D |
| 1 | 1591 | 1018 | — | Sale at price 0.64 per share. | LYNCH JEANNINE | Officer | — | 2025-09-02 00:00:00 | I |
| 2 | 35920 | — | — | Stock Award(Grant) at price 0.00 per share. | LEVY HADAR | Director | — | 2025-08-01 00:00:00 | I |
| 3 | 35920 | — | — | Stock Award(Grant) at price 0.00 per share. | SWINFORD MICHAEL | Director | — | 2025-08-01 00:00:00 | I |
| 4 | 35920 | — | — | Stock Award(Grant) at price 0.00 per share. | PODUSKA JOHN WILLIAM SR | Director | — | 2025-08-01 00:00:00 | I |
| 5 | 71839 | — | — | Stock Award(Grant) at price 0.00 per share. | TURK JOSEPH E JR | Director | — | 2025-08-01 00:00:00 | I |
| 6 | 35920 | — | — | Stock Award(Grant) at price 0.00 per share. | MARSHALL ROBERT J. JR. | Director | — | 2025-08-01 00:00:00 | D |
| 7 | 35920 | — | — | Stock Award(Grant) at price 0.00 per share. | RICHNER RANDEL E. | Director | — | 2025-08-01 00:00:00 | I |
| 8 | 1909 | 2405 | — | Sale at price 1.26 per share. | JASINSKI LAWRENCE J | Chief Executive Officer | — | 2025-05-21 00:00:00 | I |
| 9 | 6000 | 10140 | — | Purchase at price 1.69 per share. | TURK JOSEPH E JR | Director | — | 2024-12-13 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | -2.07M | 72.07 | 4.62K | 10.26K |
| TaxRateForCalcs | 0.21 | 0.00 | 0.21 | 0.27 |
| NormalizedEBITDA | -5.85M | -21.90M | -18.92M | -12.43M |
| TotalUnusualItems | -9.86M | 133.00K | 22.00K | 38.00K |
| TotalUnusualItemsExcludingGoodwill | -9.86M | 133.00K | 22.00K | 38.00K |
| NetIncomeFromContinuingOperationNetMinorityInterest | -28.94M | -22.13M | -19.57M | -12.74M |
| ReconciledDepreciation | 3.84M | 1.85M | 202.00K | 266.00K |
| ReconciledCostOfRevenue | 17.45M | 9.40M | 3.61M | 3.06M |
| EBITDA | -15.71M | -21.77M | -18.90M | -12.39M |
| EBIT | -19.55M | -23.61M | -19.10M | -12.65M |
| NetInterestIncome | 515.00K | 1.33M | -22.00K | -25.00K |
| InterestExpense | 0.00 | 0.00 | ||
| InterestIncome | 643.00K | 1.35M | 0.00 | 0.00 |
| NormalizedIncome | -21.15M | -22.27M | -19.59M | -12.76M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -28.94M | -22.13M | -19.57M | -12.74M |
| TotalExpenses | 45.22M | 37.47M | 24.61M | 18.62M |
| TotalOperatingIncomeAsReported | -29.35M | -23.61M | -19.10M | -12.65M |
| DilutedAverageShares | 8.69M | 8.53M | 8.91M | 6.85M |
| BasicAverageShares | 8.69M | 8.53M | 8.91M | 6.85M |
| DilutedEPS | -3.33 | -2.59 | -2.20 | -1.89 |
| BasicEPS | -3.33 | -2.59 | -2.17 | -1.89 |
| DilutedNIAvailtoComStockholders | -28.94M | -22.13M | -19.57M | -12.74M |
| NetIncomeCommonStockholders | -28.94M | -22.13M | -19.57M | -12.74M |
| NetIncome | -28.94M | -22.13M | -19.57M | -12.74M |
| NetIncomeIncludingNoncontrollingInterests | -28.94M | -22.13M | -19.57M | -12.74M |
| NetIncomeContinuousOperations | -28.94M | -22.13M | -19.57M | -12.74M |
| TaxProvision | 43.00K | -12.00K | 467.00K | 94.00K |
| PretaxIncome | -28.90M | -22.14M | -19.10M | -12.64M |
| OtherIncomeExpense | -9.86M | 133.00K | 22.00K | 38.00K |
| SpecialIncomeCharges | -9.79M | 0.00 | 0.00 | |
| WriteOff | 9.79M | 0.00 | 0.00 | |
| ImpairmentOfCapitalAssets | 9.79M | 0.00 | 0.00 | |
| GainOnSaleOfSecurity | -67.00K | 133.00K | 22.00K | 38.00K |
| NetNonOperatingInterestIncomeExpense | 515.00K | 1.33M | -22.00K | -25.00K |
| TotalOtherFinanceCost | 128.00K | 20.00K | 22.00K | 25.00K |
| InterestExpenseNonOperating | 0.00 | 0.00 | ||
| InterestIncomeNonOperating | 643.00K | 1.35M | 0.00 | 0.00 |
| OperatingIncome | -19.55M | -23.61M | -19.10M | -12.65M |
| OperatingExpense | 27.77M | 28.07M | 21.01M | 15.56M |
| ResearchAndDevelopment | 4.62M | 4.15M | 4.03M | 2.94M |
| SellingGeneralAndAdministration | 23.14M | 23.92M | 16.98M | 12.62M |
| SellingAndMarketingExpense | 17.95M | 13.92M | 9.84M | 6.99M |
| GeneralAndAdministrativeExpense | 5.20M | 9.99M | 7.13M | 5.63M |
| OtherGandA | 5.20M | 9.99M | 7.13M | 5.63M |
| GrossProfit | 8.22M | 4.45M | 1.91M | 2.90M |
| CostOfRevenue | 17.45M | 9.40M | 3.61M | 3.06M |
| TotalRevenue | 25.66M | 13.85M | 5.51M | 5.97M |
| OperatingRevenue | 25.66M | 13.85M | 5.51M | 5.97M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| TreasurySharesNumber | 574.66K | 574.66K | 419.03K | |
| OrdinarySharesNumber | 8.81M | 8.59M | 8.58M | 8.93M |
| ShareIssued | 9.38M | 9.16M | 9.00M | 8.93M |
| TotalDebt | 880.00K | 1.90M | 897.00K | 1.06M |
| TangibleBookValue | 11.31M | 26.45M | 68.17M | 89.38M |
| InvestedCapital | 18.85M | 46.51M | 68.17M | 89.38M |
| WorkingCapital | 11.07M | 27.43M | 67.73M | 88.48M |
| NetTangibleAssets | 11.31M | 26.45M | 68.17M | 89.38M |
| CapitalLeaseObligations | 880.00K | 1.90M | 897.00K | 1.06M |
| CommonStockEquity | 18.85M | 46.51M | 68.17M | 89.38M |
| TotalCapitalization | 18.85M | 46.51M | 68.17M | 89.38M |
| TotalEquityGrossMinorityInterest | 18.85M | 46.51M | 68.17M | 89.38M |
| StockholdersEquity | 18.85M | 46.51M | 68.17M | 89.38M |
| TreasuryStock | 3.20M | 3.20M | 2.43M | 0.00 |
| RetainedEarnings | -264.82M | -235.88M | -213.75M | -194.18M |
| AdditionalPaidInCapital | 282.29M | 281.11M | 279.86M | 278.90M |
| CapitalStock | 4.59M | 4.49M | 4.49M | 4.66M |
| CommonStock | 4.59M | 4.49M | 4.49M | 4.66M |
| TotalLiabilitiesNetMinorityInterest | 11.64M | 16.68M | 6.07M | 5.37M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 1.41M | 4.89M | 1.29M | 1.33M |
| OtherNonCurrentLiabilities | 67.00K | 2.77M | 66.00K | 45.00K |
| NonCurrentDeferredLiabilities | 1.32M | 1.51M | 890.00K | 866.00K |
| NonCurrentDeferredRevenue | 1.32M | 1.51M | 890.00K | 866.00K |
| LongTermDebtAndCapitalLeaseObligation | 22.00K | 607.00K | 333.00K | 418.00K |
| LongTermCapitalLeaseObligation | 22.00K | 607.00K | 333.00K | 418.00K |
| CurrentLiabilities | 10.22M | 11.79M | 4.78M | 4.04M |
| OtherCurrentLiabilities | 1.76M | 1.89M | 685.00K | 555.00K |
| CurrentDeferredLiabilities | 1.25M | 1.50M | 301.00K | 316.00K |
| CurrentDeferredRevenue | 1.25M | 1.50M | 301.00K | 316.00K |
| CurrentDebtAndCapitalLeaseObligation | 858.00K | 1.30M | 564.00K | 641.00K |
| CurrentCapitalLeaseObligation | 858.00K | 1.30M | 564.00K | 641.00K |
| PensionandOtherPostRetirementBenefitPlansCurrent | 2.03M | 1.28M | 1.14M | |
| PayablesAndAccruedExpenses | 6.35M | 7.10M | 3.23M | 2.53M |
| CurrentAccruedExpenses | 1.33M | 2.03M | 1.28M | 1.14M |
| Payables | 5.02M | 5.07M | 1.95M | 1.38M |
| AccountsPayable | 5.02M | 5.07M | 1.95M | 1.38M |
| TotalAssets | 30.49M | 63.19M | 74.24M | 94.75M |
| TotalNonCurrentAssets | 9.19M | 23.97M | 1.73M | 2.23M |
| OtherNonCurrentAssets | 240.00K | 784.00K | 694.00K | 1.06M |
| GoodwillAndOtherIntangibleAssets | 7.54M | 20.06M | 0.00 | |
| OtherIntangibleAssets | 12.53M | |||
| Goodwill | 7.54M | 7.54M | 0.00 | |
| NetPPE | 1.42M | 3.12M | 1.03M | 1.17M |
| AccumulatedDepreciation | -7.03M | -6.34M | -3.62M | -3.42M |
| GrossPPE | 8.45M | 9.46M | 4.66M | 4.59M |
| Leases | 658.00K | 658.00K | 333.00K | 333.00K |
| OtherProperties | 5.01M | 6.03M | 2.65M | 2.59M |
| MachineryFurnitureEquipment | 2.78M | 2.78M | 1.67M | 1.66M |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 21.29M | 39.22M | 72.51M | 92.52M |
| OtherCurrentAssets | 578.00K | 1.00M | 233.00K | 270.00K |
| RestrictedCash | 197.00K | 0.00 | ||
| PrepaidAssets | 1.05M | 1.37M | 416.00K | 340.00K |
| Inventory | 6.72M | 5.65M | 2.93M | 2.99M |
| FinishedGoods | 3.58M | 3.16M | 2.42M | 2.28M |
| RawMaterials | 3.14M | 2.50M | 508.00K | 705.00K |
| Receivables | 6.00M | 3.12M | 1.04M | 585.00K |
| AccountsReceivable | 6.00M | 3.12M | 1.04M | 585.00K |
| AllowanceForDoubtfulAccountsReceivable | -160.00K | -328.00K | -26.00K | |
| GrossAccountsReceivable | 6.16M | 3.45M | 1.06M | |
| CashCashEquivalentsAndShortTermInvestments | 6.75M | 28.08M | 67.90M | 88.34M |
| CashAndCashEquivalents | 6.75M | 28.08M | 67.90M | 88.34M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -21.72M | -20.75M | -17.92M | -11.52M |
| RepurchaseOfCapitalStock | 0.00 | -992.00K | -2.50M | 0.00 |
| RepaymentOfDebt | 0.00 | 0.00 | ||
| IssuanceOfDebt | 0.00 | 0.00 | ||
| IssuanceOfCapitalStock | 0.00 | 0.00 | 64.45M | |
| CapitalExpenditure | -81.00K | -25.00K | -47.00K | |
| InterestPaidSupplementalData | 1.34M | 0.00 | 0.00 | |
| IncomeTaxPaidSupplementalData | 126.00K | 113.00K | 40.00K | |
| EndCashPosition | 7.11M | 28.79M | 68.56M | 89.05M |
| BeginningCashPosition | 28.79M | 68.56M | 89.05M | 21.05M |
| EffectOfExchangeRateChanges | 34.00K | 45.00K | -79.00K | 0.00 |
| ChangesInCash | -21.72M | -39.81M | -20.42M | 68.00M |
| FinancingCashFlow | 0.00 | -992.00K | -2.50M | 79.51M |
| CashFlowFromContinuingFinancingActivities | 0.00 | -992.00K | -2.50M | 79.51M |
| ProceedsFromStockOptionExercised | 0.00 | 0.00 | 15.06M | |
| NetCommonStockIssuance | 0.00 | -992.00K | -2.50M | 64.45M |
| CommonStockPayments | 0.00 | -992.00K | -2.50M | 0.00 |
| CommonStockIssuance | 0.00 | 0.00 | 64.45M | |
| NetIssuancePaymentsOfDebt | 0.00 | 0.00 | ||
| NetLongTermDebtIssuance | 0.00 | 0.00 | ||
| LongTermDebtPayments | 0.00 | 0.00 | ||
| LongTermDebtIssuance | 0.00 | 0.00 | ||
| InvestingCashFlow | 0.00 | -18.15M | -25.00K | -47.00K |
| CashFlowFromContinuingInvestingActivities | 0.00 | -18.15M | -25.00K | -47.00K |
| NetBusinessPurchaseAndSale | 0.00 | -18.07M | 0.00 | 0.00 |
| PurchaseOfBusiness | 0.00 | -18.07M | 0.00 | 0.00 |
| NetPPEPurchaseAndSale | 0.00 | -81.00K | -25.00K | -47.00K |
| PurchaseOfPPE | 0.00 | -81.00K | -25.00K | -47.00K |
| OperatingCashFlow | -21.72M | -20.67M | -17.89M | -11.47M |
| CashFlowFromContinuingOperatingActivities | -21.72M | -20.67M | -17.89M | -11.47M |
| ChangeInWorkingCapital | -4.97M | -1.34M | 88.00K | 197.00K |
| ChangeInOtherWorkingCapital | -438.00K | -269.00K | -34.00K | 74.00K |
| ChangeInOtherCurrentLiabilities | -1.37M | -973.00K | -153.00K | -391.00K |
| ChangeInPayablesAndAccruedExpense | -749.00K | 1.02M | 706.00K | -609.00K |
| ChangeInAccruedExpense | -702.00K | -14.00K | 140.00K | 275.00K |
| ChangeInPayable | -47.00K | 1.04M | 566.00K | -884.00K |
| ChangeInAccountPayable | -47.00K | 1.04M | 566.00K | -884.00K |
| ChangeInPrepaidAssets | 1.38M | -531.00K | 94.00K | 592.00K |
| ChangeInInventory | -920.00K | -277.00K | -117.00K | 432.00K |
| ChangeInReceivables | -2.88M | -311.00K | -408.00K | 99.00K |
| ChangesInAccountReceivables | -2.88M | -311.00K | -408.00K | 99.00K |
| OtherNonCashItems | -2.68M | -326.00K | ||
| StockBasedCompensation | 1.28M | 1.33M | 993.00K | 833.00K |
| AssetImpairmentCharge | 9.79M | 0.00 | 0.00 | |
| DeferredTax | 0.00 | 0.00 | 316.00K | -29.00K |
| DeferredIncomeTax | 0.00 | 0.00 | 316.00K | -29.00K |
| DepreciationAmortizationDepletion | 3.84M | 1.85M | 202.00K | 266.00K |
| DepreciationAndAmortization | 3.84M | 1.85M | 202.00K | 266.00K |
| AmortizationCashFlow | 3.35M | 1.61M | 0.00 | 0.00 |
| AmortizationOfIntangibles | 3.35M | 1.61M | 0.00 | 0.00 |
| Depreciation | 494.00K | 239.00K | 202.00K | 266.00K |
| OperatingGainsLosses | -34.00K | -45.00K | 79.00K | |
| NetForeignCurrencyExchangeGainLoss | -34.00K | -45.00K | 79.00K | 0.00 |
| NetIncomeFromContinuingOperations | -28.94M | -22.13M | -19.57M | -12.74M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for LFWD
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|